Citations (187)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Lucie Hyrsova, Tomas Smutny, Frantisek Trejtnar & Petr Pavek. (2016) Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation. Drug Metabolism Reviews 48:2, pages 139-158.
Read now
Read now
R. J. Riley, S. A. Foley, P. Barton, M. G. Soars & B. Williamson. (2016) Hepatic drug transporters: the journey so far. Expert Opinion on Drug Metabolism & Toxicology 12:2, pages 201-216.
Read now
Read now
Xiaoyan Chu, Kelly Bleasby & Raymond Evers. (2013) Species differences in drug transporters and implications for translating preclinical findings to humans. Expert Opinion on Drug Metabolism & Toxicology 9:3, pages 237-252.
Read now
Read now
Frantisek Staud, Lukas Cerveny & Martina Ceckova. (2012) Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. Journal of Drug Targeting 20:9, pages 736-763.
Read now
Read now
Oliver Zolk. (2012) Disposition of metformin: Variability due to polymorphisms of organic cation transporters. Annals of Medicine 44:2, pages 119-129.
Read now
Read now
Xi-Ling Jiang, Frank J. Gonzalez & Ai-Ming Yu. (2011) Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models. Drug Metabolism Reviews 43:1, pages 27-40.
Read now
Read now
Giuliano Ciarimboli. (2011) Role of organic cation transporters in drug-induced toxicity. Expert Opinion on Drug Metabolism & Toxicology 7:2, pages 159-174.
Read now
Read now
Norma Jung & Dirk Taubert. (2009) Organic cation transporters and their roles in antiretroviral drug disposition. Expert Opinion on Drug Metabolism & Toxicology 5:7, pages 773-787.
Read now
Read now
G. Ciarimboli. (2008) Organic cation transporters. Xenobiotica 38:7-8, pages 936-971.
Read now
Read now
Adrian Vella & Michael Camilleri. (2008) Pharmacogenetics: potential role in the treatment of diabetes and obesity. Expert Opinion on Pharmacotherapy 9:7, pages 1109-1119.
Read now
Read now
Isa E. L. M. Kuppens, P. Breedveld, J. H. Beijnen & J. H. M. Schellens. (2005) Modulation of Oral Drug Bioavailability: From Preclinical Mechanism to Therapeutic Application. Cancer Investigation 23:5, pages 443-464.
Read now
Read now
Johan W. Jonker, Els Wagenaar, Sven van Eijl & Alfred H. Schinkel. (2003) Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations. Molecular and Cellular Biology 23:21, pages 7902-7908.
Read now
Read now
Articles from other publishers (175)
Antonio J. López Quiñones, Letícia Salvador Vieira & Joanne Wang. (2022)
Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of
meta
-Iodobenzylguanidine
. Drug Metabolism and Disposition 50:9, pages 1218-1227.
Crossref
Crossref
Eugene C. Chen, Pär Matsson, Mina Azimi, Xujia Zhou, Niklas Handin, Sook Wah Yee, Per Artursson & Kathleen M. Giacomini. (2022) High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3. Pharmaceutical Research 39:7, pages 1599-1613.
Crossref
Crossref
Laura Di Magno, Fiorella Di Pastena, Rosa Bordone, Sonia Coni & Gianluca Canettieri. (2022) The Mechanism of Action of Biguanides: New Answers to a Complex Question. Cancers 14:13, pages 3220.
Crossref
Crossref
Megan L. Koleske, Xiaomin Liang, Osatohanmwen Jessica Enogieru, Dina Buitrago & Kathleen M. Giacomini. 2022. Drug Transporters. Drug Transporters
9
32
.
Melanie A. Felmlee & Qing Zhang. 2022. Drug Transporters. Drug Transporters
393
412
.
Stefan Oswald. 2022. Drug Transporters. Drug Transporters
333
359
.
Philip Sandoval & Bruno Hagenbuch. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
585
607
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
745
751
.
Anne‐Margarethe Enge, Florian Kaltner, Christoph Gottschalk, Angelina Kin, Michael Kirstgen, Joachim Geyer, Anja These, Helen Hammer, Oliver Pötz, Albert Braeuning & Stefanie Hessel‐Pras. (2021)
Organic Cation Transporter I and Na
+
/taurocholate Co‐Transporting Polypeptide are Involved in Retrorsine‐ and Senecionine‐Induced Hepatotoxicity in HepaRG cells
. Molecular Nutrition & Food Research 66:2, pages 2100800.
Crossref
Crossref
Shreyas Bhat, Ali El-Kasaby, Michael Freissmuth & Sonja Sucic. (2021) Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits. Pharmacology & Therapeutics 222, pages 107785.
Crossref
Crossref
Bridget L. Morse, John K. Fallon, Anil Kolur, Andrew T. Hogan, Philip C. Smith & Kathleen M. Hillgren. (2021) Comparison of Hepatic Transporter Tissue Expression in Rodents and Interspecies Hepatic OCT1 Activity. The AAPS Journal 23:3.
Crossref
Crossref
Christoph Wenzel, Marek Drozdzik & Stefan Oswald. (2021) Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?. Frontiers in Pharmacology 12.
Crossref
Crossref
Muhammad Erfan Uddin, Dominique A. Garrison, Kyeongmin Kim, Yan Jin, Eric D. Eisenmann, Kevin M. Huang, Alice A. Gibson, Zeping Hu, Alex Sparreboom & Shuiying Hu. (2021) Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1. Frontiers in Pharmacology 12.
Crossref
Crossref
Irene Hernández-Lozano, Severin Mairinger, Michael Sauberer, Johann Stanek, Thomas Filip, Thomas Wanek, Giuliano Ciarimboli, Nicolas Tournier & Oliver Langer. (2021) Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [11C]Metoclopramide in Mice. Pharmaceutical Research 38:1, pages 127-140.
Crossref
Crossref
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
6
.
Lynette C. Daws. 2021. Organic Cation Transporters in the Central Nervous System. Organic Cation Transporters in the Central Nervous System
215
239
.
Matthias Gorecki, Simon F. Müller, Regina Leidolf & Joachim Geyer. (2020) Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families. International Journal of Molecular Sciences 22:1, pages 22.
Crossref
Crossref
Yvonne E. Arnold & Yogeshvar N. Kalia. (2020) Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early—Stage Drug Development. Biomedicines 8:9, pages 340.
Crossref
Crossref
Antonio J. López Quiñones, David J. Wagner & Joanne Wang. (2020)
Characterization of
Meta
-Iodobenzylguanidine (mIBG) Transport by Polyspecific Organic Cation Transporters: Implication for mIBG Therapy
. Molecular Pharmacology 98:2, pages 109-119.
Crossref
Crossref
Pablo Zubiaur, Miriam Saiz-Rodríguez, Dolores Ochoa, Marcos Navares-Gómez, Gina Mejía, Manuel Román, Dora Koller, Paula Soria-Chacartegui, Susana Almenara & Francisco Abad-Santos. (2020) Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran. Advances in Therapy 37:8, pages 3537-3550.
Crossref
Crossref
Catarina Chaves, Federica Campanelli, Hélène Chapy, David Gomez-Zepeda, Fabienne Glacial, Maria Smirnova, Meryam Taghi, Johan Pallud, Nicolas Perrière, Xavier Declèves, Marie-Claude Menet & Salvatore Cisternino. (2020) An Interspecies Molecular and Functional Study of Organic Cation Transporters at the Blood-Brain Barrier: From Rodents to Humans. Pharmaceutics 12:4, pages 308.
Crossref
Crossref
Bayew Tsega Abebe, Michael Weiss, Christiane Modess, Tobias Tadken, Danilo Wegner, Marleen J. Meyer, Ulrich Schwantes, Claudia Neumeister, Eberhard Scheuch, Hans‐Ulrich Schulz, Mladen Tzvetkov & Werner Siegmund. (2019) Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects. The Journal of Clinical Pharmacology 60:3, pages 312-323.
Crossref
Crossref
Bridget L. Morse, Anil Kolur, Loyd R. Hudson, Andrew T. Hogan, Lisa Hong Chen, Ryan M. Brackman, Geri A. Sawada, John K. Fallon, Philip C. Smith & Kathleen M. Hillgren. (2020) Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake. Drug Metabolism and Disposition 48:2, pages 93-105.
Crossref
Crossref
Robert S. Jones, Justin Q. Ly & Jae H. Chang. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters
555
594
.
Danyi Lu, Menglin Chen, Yi Wang, Min Chen & Baojian Wu. 2020. Circadian Pharmacokinetics. Circadian Pharmacokinetics
131
158
.
Jason T. Anderson, Kevin M. Huang, Maryam B. Lustberg, Alex Sparreboom & Shuiying Hu. 2022. Targets of Cancer Diagnosis and Treatment. Targets of Cancer Diagnosis and Treatment
177
215
.
Bayew Tsega Abebe, Michael Weiss, Christiane Modess, Tarek Roustom, Tobias Tadken, Danilo Wegner, Ulrich Schwantes, Claudia Neumeister, Hans‐Ulrich Schulz, Eberhard Scheuch & Werner Siegmund. (2019) Effects of the P‐Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4‐Way Crossover Drug‐Drug Interaction Study in Healthy Subjects. The Journal of Clinical Pharmacology 59:10, pages 1319-1330.
Crossref
Crossref
Marco F. Taddio, Linjing Mu, Claudia A. Castro Jaramillo, Tanja Bollmann, Dominik M. Schmid, Lukas P. Muskalla, Tim Gruene, Aristeidis Chiotellis, Simon M. Ametamey, Roger Schibli & Stefanie D. Krämer. (2019) Synthesis and Structure–Affinity Relationship of Small Molecules for Imaging Human CD80 by Positron Emission Tomography. Journal of Medicinal Chemistry 62:17, pages 8090-8100.
Crossref
Crossref
Dianlei Wang. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity
203
240
.
Yuichi Uwai. (2018) Enantioselective Drug Recognition by Drug Transporters. Molecules 23:12, pages 3062.
Crossref
Crossref
T. Lee Gilman, Christina M. George, Melissa Vitela, Myrna Herrera-Rosales, Mohamed S. Basiouny, Wouter Koek & Lynette C. Daws. (2018)
Constitutive plasma membrane monoamine transporter (PMAT,
Slc29a4
) deficiency subtly affects anxiety-like and coping behaviours
. European Journal of Neuroscience 48:1, pages 1706-1716.
Crossref
Crossref
Fabian Müller, Ashish Sharma, Jörg König & Martin F. Fromm. (2018) Biomarkers for In Vivo Assessment of Transporter Function. Pharmacological Reviews 70:2, pages 246-277.
Crossref
Crossref
Sanjay K. Nigam. (2018) The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease. Annual Review of Pharmacology and Toxicology 58:1, pages 663-687.
Crossref
Crossref
Hannah C.D. Esdal, Muhammad B. Ghbeis, Daniel A. Saltzman, Donavon Hess, Janet R. Hume, Robyn C. Reed, Susan A. Berry, Eric Hoggard, Betsy Hirsch, Linda B. Baughn & Lisa A. Schimmenti. (2018) Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions. Molecular Syndromology 9:3, pages 141-148.
Crossref
Crossref
J.E. Manautou & C.I. Ghanem. 2018. Comprehensive Toxicology. Comprehensive Toxicology
215
276
.
R.H. Ho & R.B. Kim. 2018. Comprehensive Toxicology. Comprehensive Toxicology
574
616
.
Xiaomin Liang & Kathleen M. Giacomini. (2017) Transporters Involved in Metformin Pharmacokinetics and Treatment Response. Journal of Pharmaceutical Sciences 106:9, pages 2245-2250.
Crossref
Crossref
Joachim Neumann, Britt Hofmann & Ulrich Gergs. 2017. Serotonin - A Chemical Messenger Between All Types of Living Cells. Serotonin - A Chemical Messenger Between All Types of Living Cells.
Yan Li, Jezrael Revalde & James W. Paxton. (2017) The effects of dietary and herbal phytochemicals on drug transporters. Advanced Drug Delivery Reviews 116, pages 45-62.
Crossref
Crossref
Pierre-André Billat, Emilie Roger, Sébastien Faure & Frédéric Lagarce. (2017) Models for drug absorption from the small intestine: where are we and where are we going?. Drug Discovery Today 22:5, pages 761-775.
Crossref
Crossref
Marcus Otter, Stefan Oswald, Werner Siegmund & Markus Keiser. (2017) Effects of frequently used pharmaceutical excipients on the organic cation transporters 1–3 and peptide transporters 1/2 stably expressed in MDCKII cells. European Journal of Pharmaceutics and Biopharmaceutics 112, pages 187-195.
Crossref
Crossref
Tobias Tadken, Michael Weiss, Christiane Modess, Danilo Wegner, Tarek Roustom, Claudia Neumeister, Ulrich Schwantes, Hans-Ulrich Schulz, Werner Weitschies & Werner Siegmund. (2016) Trospium chloride is absorbed from two intestinal “absorption windows” with different permeability in healthy subjects. International Journal of Pharmaceutics 515:1-2, pages 367-373.
Crossref
Crossref
Shin-ya Maruyama, Momoe Ito, Yuusuke Ikami, Yu Okitsu, Chizuru Ito, Kiyotaka Toshimori, Wataru Fujii & Keiichiro Yogo. (2016) A critical role of solute carrier 22a14 in sperm motility and male fertility in mice. Scientific Reports 6:1.
Crossref
Crossref
Ulrike M. Stamer, Frank Musshoff, Frank Stüber, Jürgen Brockmöller, Michael Steffens & Mladen V. Tzvetkov. (2016) Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption. Pain 157:11, pages 2467-2475.
Crossref
Crossref
Marilyn E. Morris & Xiaowen Guan. 2016. Drug Delivery. Drug Delivery
62
102
.
Bertrand Le Roy, Lucie Tixier, Bruno Pereira, Pierre Sauvanet, Emmanuel Buc, Caroline Pétorin, Pierre Déchelotte, Denis Pezet & David Balayssac. (2016) Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study. PLOS ONE 11:2, pages e0148739.
Crossref
Crossref
William R. Proctor, Xin Ming, David Bourdet, Tianxiang (Kevin) Han, Ruth S. Everett & Dhiren R. Thakker. (2016) Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis. Journal of Pharmaceutical Sciences 105:2, pages 484-496.
Crossref
Crossref
Yuta Tanaka, Yoshiaki Kitamura, Kazuya Maeda & Yuichi Sugiyama. (2016) Explication of Definitional Description and Empirical Use of Fraction of Orally Administered Drugs Absorbed From the Intestine (F a ) and Intestinal Availability (F g ): Effect of P-glycoprotein and CYP3A on F a and F g. Journal of Pharmaceutical Sciences 105:2, pages 431-442.
Crossref
Crossref
Ivan Sabolić, Davorka Breljak & Tvrtko Smital. 2016. Organic Cation Transporters. Organic Cation Transporters
217
242
.
Alejandro Orrico & Sophie Gautron. 2016. Organic Cation Transporters. Organic Cation Transporters
187
204
.
Hideyuki Motohashi & Ken-ichi Inui. 2016. Organic Cation Transporters. Organic Cation Transporters
73
92
.
Giuliano Ciarimboli. 2016. Organic Cation Transporters. Organic Cation Transporters
1
47
.
Xiaomin Liang, Huan-Chieh Chien, Sook Wah Yee, Marilyn M. Giacomini, Eugene C. Chen, Meiling Piao, Jia Hao, Jolyn Twelves, Eve-Irene Lepist, Adrian S. Ray & Kathleen M. Giacomini. (2015) Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3). Molecular Pharmaceutics 12:12, pages 4301-4310.
Crossref
Crossref
Tina Seitz, Robert Stalmann, Nawar Dalila, Jiayin Chen, Sherin Pojar, Joao N. Dos Santos Pereira, Ralph Krätzner, Jürgen Brockmöller & Mladen V. Tzvetkov. (2015) Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1. Genome Medicine 7:1.
Crossref
Crossref
Sook Wah Yee, Lawrence Lin, Matthew Merski, Michael J. Keiser, Aakash Gupta, Youcai Zhang, Huan-Chieh Chien, Brian K. Shoichet & Kathleen M. Giacomini. (2015) Prediction and validation of enzyme and transporter off-targets for metformin. Journal of Pharmacokinetics and Pharmacodynamics 42:5, pages 463-475.
Crossref
Crossref
Marialuisa Polillo, Sara Galimberti, Claudia Baratè, Mario Petrini, Romano Danesi & Antonello Di Paolo. (2015) Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia. International Journal of Molecular Sciences 16:9, pages 22811-22829.
Crossref
Crossref
Eugene C. Chen, Xiaomin Liang, Sook Wah Yee, Ethan G. Geier, Sophie L. Stocker, Ligong Chen & Kathleen M. Giacomini. (2015) Targeted Disruption of Organic Cation Transporter 3 Attenuates the Pharmacologic Response to Metformin. Molecular Pharmacology 88:1, pages 75-83.
Crossref
Crossref
Yoshihisa Mimura, Tomoya Yasujima, Kinya Ohta, Katsuhisa Inoue & Hiroaki Yuasa. (2015) Functional identification of organic cation transporter 1 as an atenolol transporter sensitive to flavonoids. Biochemistry and Biophysics Reports 2, pages 166-171.
Crossref
Crossref
Tanja Dujic, Kaixin ZhouLouise A. DonnellyRoger TavendaleColin N.A. PalmerEwan R. Pearson. (2015) Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study. Diabetes 64:5, pages 1786-1793.
Crossref
Crossref
Naree Shin, Ju-Hee Oh & Young-Joo Lee. (2015) Role of drug transporters: an overview based on knockout animal model studies. Journal of Pharmaceutical Investigation 45:2, pages 101-114.
Crossref
Crossref
Thomas Couroussé & Sophie Gautron. (2015) Role of organic cation transporters (OCTs) in the brain. Pharmacology & Therapeutics 146, pages 94-103.
Crossref
Crossref
Sanjay K. Nigam. (2014) What do drug transporters really do?. Nature Reviews Drug Discovery 14:1, pages 29-44.
Crossref
Crossref
Erika F. Dahl, Casey D. Wright & Timothy D. O’Connell. 2015. Nuclear G-Protein Coupled Receptors. Nuclear G-Protein Coupled Receptors
43
52
.
Zidong Donna Fu, Julia Yue Cui & Curtis D. Klaassen. (2014) Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice. Journal of Lipid Research 55:12, pages 2576-2586.
Crossref
Crossref
Serena Marchetti & Jan H. M. Schellens. 2014. Drug Transporters. Drug Transporters
433
471
.
A Di Paolo, M Polillo, M Capecchi, G Cervetti, C Baratè, S Angelini, F Guerrini, G Fontanelli, R Arici, E Ciabatti, S Grassi, G Bocci, P Hrelia, R Danesi, M Petrini & S Galimberti. (2014) The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. The Pharmacogenomics Journal 14:4, pages 328-335.
Crossref
Crossref
Ligong ChenYan ShuXiaomin LiangEugene C. ChenSook Wah YeeArik A. ZurShuanglian LiLu XuKayvan R. KeshariMichael J. LinHuan-Chieh ChienYoucai ZhangKari M. MorrisseyJason LiuJonathan Ostrem, Noah S. Younger, John KurhanewiczKevan M. Shokat, Kaveh AshrafiKathleen M. Giacomini. (2014) OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proceedings of the National Academy of Sciences 111:27, pages 9983-9988.
Crossref
Crossref
Anne T. Nies, Elke Schaeffeler, Heiko van der Kuip, Ingolf Cascorbi, Oliver Bruhn, Michael Kneba, Christiane Pott, Ute Hofmann, Christopher Volk, Shuiying Hu, Sharyn D. Baker, Alex Sparreboom, Peter Ruth, Hermann Koepsell & Matthias Schwab. (2014) Cellular Uptake of Imatinib into Leukemic Cells Is Independent of Human Organic Cation Transporter 1 (OCT1). Clinical Cancer Research 20:4, pages 985-994.
Crossref
Crossref
Richard H. Ho & Richard B. Kim. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
401
442
.
Seng Chuan Tang, Jeroen JMA Hendrikx, Jos H Beijnen & Alfred H Schinkel. (2013) Genetically modified mouse models for oral drug absorption and disposition. Current Opinion in Pharmacology 13:6, pages 853-858.
Crossref
Crossref
Valerie P. O’Brien, Kristin Bokelmann, Jacqueline Ramírez, Karoline Jobst, Mark J. Ratain, Jürgen Brockmöller & Mladen V. Tzvetkov. (2013)
Hepatocyte Nuclear Factor 1 Regulates the Expression of the Organic Cation Transporter 1 via Binding to an Evolutionary Conserved Region in Intron 1 of the
OCT1
Gene
. Journal of Pharmacology and Experimental Therapeutics 347:1, pages 181-192.
Crossref
Crossref
Tianxiang (Kevin) Han, Ruth S. Everett, William R. Proctor, Chee M. Ng, Chester L. Costales, Kim L. R. Brouwer & Dhiren R. Thakker. (2013) Organic Cation Transporter 1 (OCT1/mOct1) Is Localized in the Apical Membrane of Caco-2 Cell Monolayers and Enterocytes. Molecular Pharmacology 84:2, pages 182-189.
Crossref
Crossref
Thomayant Prueksaritanont, Xiaoyan Chu, Christopher Gibson, Donghui Cui, Ka Lai Yee, Jeanine Ballard, Tamara Cabalu & Jerome Hochman. (2013) Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective. The AAPS Journal 15:3, pages 629-645.
Crossref
Crossref
Hideyuki Motohashi & Ken-ichi Inui. (2013) Organic Cation Transporter OCTs (SLC22) and MATEs (SLC47) in the Human Kidney. The AAPS Journal 15:2, pages 581-588.
Crossref
Crossref
I.S. Song, M.K. Choi, W.S. Shim & C.K. Shim. (2013) Transport of organic cationic drugs: Effect of ion-pair formation with bile salts on the biliary excretion and pharmacokinetics. Pharmacology & Therapeutics 138:1, pages 142-154.
Crossref
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
675
718
.
Alexander V. LyubimovAndrew Bessire, Kuresh Youdim, Susan Hurst & Caroline A. Lee. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
88
.
Alexander V. LyubimovJasminder Sahi, Yurong Lai & Caroline Lee. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
51
.
Thomas F. Gallegos, Gleb Martovetsky, Valentina Kouznetsova, Kevin T. Bush & Sanjay K. Nigam. (2012) Organic Anion and Cation SLC22 “Drug” Transporter (Oat1, Oat3, and Oct1) Regulation during Development and Maturation of the Kidney Proximal Tubule. PLoS ONE 7:7, pages e40796.
Crossref
Crossref
J. William Higgins, David W. Bedwell & Maciej J. Zamek-Gliszczynski. (2012) Ablation of Both Organic Cation Transporter (Oct)1 and Oct2 Alters Metformin Pharmacokinetics but Has No Effect on Tissue Drug Exposure and Pharmacodynamics. Drug Metabolism and Disposition 40:6, pages 1170-1177.
Crossref
Crossref
Imad Hanna & Ryan M. Pelis. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
29
54
.
Xi‐Ling Jiang & Ai‐Ming Yu. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
235
454
.
Kevin L. Salyers & Yang Xu. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
253
276
.
Henriette E. Meyer zu Schwabedissen, Markus Grube & Heyo K. Kroemer. 2012. Pharmacogenetics and Individualized Therapy. Pharmacogenetics and Individualized Therapy
101
148
.
Megan Roth, Amanda Obaidat & Bruno Hagenbuch. (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. British Journal of Pharmacology 165:5, pages 1260-1287.
Crossref
Crossref
Kazuyoshi Yoshii, Masamichi Hirayama, Toshifumi Nakamura, Ryoko Toda, Junko Hasegawa, Mineo Takei, Yukinori Mera & Yoshihiro Kawabata. (2011) Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach. Journal of Pharmaceutical Sciences 100:11, pages 4965-4973.
Crossref
Crossref
Ryan M. Pelis & Stephen H. Wright. 2011. Comprehensive Physiology. Comprehensive Physiology
1795
1835
.
Takashi Sekine & Hiroyuki Kusuhara. 2011. Oral Bioavailability. Oral Bioavailability
309
327
.
M K DeGorter & R B Kim. (2011) Use of Transgenic and Knockout Mouse Models to Assess Solute Carrier Transporter Function. Clinical Pharmacology & Therapeutics 89:4, pages 612-616.
Crossref
Crossref
M J Kim, P Skewes-Cox, H Fukushima, S Hesselson, S W Yee, L B Ramsey, L Nguyen, J L Eshragh, R A Castro, C C Wen, D Stryke, S J Johns, T E Ferrin, P-Y Kwok, M V Relling, K M Giacomini, D L Kroetz & N Ahituv. (2011) Functional Characterization of Liver Enhancers That Regulate Drug-Associated Transporters. Clinical Pharmacology & Therapeutics 89:4, pages 571-578.
Crossref
Crossref
Jayabalan Nirmal, Thirumurthy Velpandian, Sundararajan Baskar Singh, Nihar Ranjan Biswas, Vasantha Thavaraj, Rajvardhan Azad & Supriyo Ghose. (2011) Development and validation of a highly sensitive LC–MS/MS method for organic cation transporter (OCT) substrate tetraethylammonium (TEA) in rabbits. Journal of Chromatography B 879:9-10, pages 585-590.
Crossref
Crossref
Shuanglian Li, Ying Chen, Shuzhong Zhang, Swati S. More, Xiaozhu Huang & Kathleen M. Giacomini. (2010) Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice. Pharmaceutical Research 28:3, pages 610-625.
Crossref
Crossref
Anne T. Nies, Hermann Koepsell, Katja Damme & Matthias Schwab. 2011. Drug Transporters. Drug Transporters
105
167
.
Anne Amphoux, Mark J. Millan, Alex Cordi, Heinz Bönisch, Vincent Vialou, Clotilde Mannoury la Cour, Delphine S. Dupuis, Bruno Giros & Sophie Gautron. (2010) Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: A comparison to human α1- and α2-adrenoceptor subtypes. European Journal of Pharmacology 634:1-3, pages 1-9.
Crossref
Crossref
Shayne Cox GadJan H. Beumer, Julie L. Eiseman & Merrill J. Egorin. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Curtis D. Klaassen & Lauren M. Aleksunes. (2010) Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation. Pharmacological Reviews 62:1, pages 1-96.
Crossref
Crossref
Kathleen M. Giacomini, Shiew-Mei Huang, Donald J. Tweedie, Leslie Z. Benet, Kim L.R. Brouwer, Xiaoyan Chu, Amber Dahlin, Raymond Evers, Volker Fischer, Kathleen M. Hillgren, Keith A. Hoffmaster, Toshihisa Ishikawa, Dietrich Keppler, Richard B. Kim, Caroline A. Lee, Mikko Niemi, Joseph W. Polli, Yuicchi Sugiyama, Peter W. Swaan, Joseph A. Ware, Stephen H. Wright, Sook Wah Yee, Maciej J. Zamek-Gliszczynski & Lei Zhang. (2010) Membrane transporters in drug development. Nature Reviews Drug Discovery 9:3, pages 215-236.
Crossref
Crossref
J.E. Manautou, S.N. Campion & L.M. Aleksunes. 2010. Comprehensive Toxicology. Comprehensive Toxicology
175
220
.
R.H. Ho & R.B. Kim. 2010. Comprehensive Toxicology. Comprehensive Toxicology
519
556
.
O Zolk. (2009) Current Understanding of the Pharmacogenomics of Metformin. Clinical Pharmacology & Therapeutics 86:6, pages 595-598.
Crossref
Crossref
K K Filipski, R H Mathijssen, T S Mikkelsen, A H Schinkel & A Sparreboom. (2009) Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity. Clinical Pharmacology & Therapeutics 86:4, pages 396-402.
Crossref
Crossref
M V Tzvetkov, S V Vormfelde, D Balen, I Meineke, T Schmidt, D Sehrt, I Sabolić, H Koepsell & J Brockmöller. (2009) The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin. Clinical Pharmacology & Therapeutics 86:3, pages 299-306.
Crossref
Crossref
Alice Cristina Rodrigues, Rui Curi, Fabiana Dalla Vecchia Genvigir, Mario Hiroyuki Hirata & Rosario Dominguez Crespo Hirata. (2009) The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells. Acta Pharmacologica Sinica 30:7, pages 956-964.
Crossref
Crossref
Kaixin ZhouLouise A. DonnellyCharlotte H. KimberPeter T. DonnanAlex S.F. DoneyGraham LeeseAndrew T. HattersleyMark I. McCarthyAndrew D. MorrisColin N.A. PalmerEwan R. Pearson. (2009)
Reduced-Function
SLC22A1
Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
. Diabetes 58:6, pages 1434-1439.
Crossref
Crossref
Masahiro Tsuda, Tomohiro Terada, Tomoyuki Mizuno, Toshiya Katsura, Jin Shimakura & Ken-ichi Inui. (2009)
Targeted Disruption of the Multidrug and Toxin Extrusion 1 (
Mate1
) Gene in Mice Reduces Renal Secretion of Metformin
. Molecular Pharmacology 75:6, pages 1280-1286.
Crossref
Crossref
Nirish Shah, Sandeep Khurana, Kunrong Cheng & Jean-Pierre Raufman. (2009) Muscarinic receptors and ligands in cancer. American Journal of Physiology-Cell Physiology 296:2, pages C221-C232.
Crossref
Crossref
Richard H. Ho & Richard B. Kim. 2010. Handbook of Drug-Nutrient Interactions. Handbook of Drug-Nutrient Interactions
45
84
.
Kazuya Maeda, Hiroshi Suzuki & Yuichi Sugiyama. 2008. Drug Bioavailability. Drug Bioavailability
277
332
.
Tomoko Sato, Satohiro Masuda, Atsushi Yonezawa, Yuko Tanihara, Toshiya Katsura & Ken-ichi Inui. (2008) Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1. Biochemical Pharmacology 76:7, pages 894-903.
Crossref
Crossref
Hani Zaher, Henriette E. Meyer zu Schwabedissen, Rommel G. Tirona, Melissa L. Cox, Leslie A. Obert, Nidhi Agrawal, Joe Palandra, Jeffrey L. Stock, Richard B. Kim & Joseph A. Ware. (2008)
Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/
Slco1b2
) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin
. Molecular Pharmacology 74:2, pages 320-329.
Crossref
Crossref
Curtis D. Klaassen & Hong Lu. (2008) Xenobiotic Transporters: Ascribing Function from Gene Knockout and Mutation Studies. Toxicological Sciences 101:2, pages 186-196.
Crossref
Crossref
Y Shu, C Brown, RA Castro, RJ Shi, ET Lin, RP Owen, SA Sheardown, L Yue, EG Burchard, CM Brett & KM Giacomini. (2007) Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics. Clinical Pharmacology & Therapeutics 83:2, pages 273-280.
Crossref
Crossref
Tomoji Maeda, Takafumi Yotsumoto, Masanobu Oyabu & Ikumi Tamai. (2008) Effect of Glucocorticoid Receptor Ligand Dexamethasone on the Expression of Organic Cation Transporter in Rat Liver. Drug Metabolism and Pharmacokinetics 23:1, pages 67-72.
Crossref
Crossref
Min-Koo Choi & Im-Sook Song. (2008) Organic Cation Transporters and their Pharmacokinetic and Pharmacodynamic Consequences. Drug Metabolism and Pharmacokinetics 23:4, pages 243-253.
Crossref
Crossref
Gerhard Burckhardt & Hermann Koepsell. 2008. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney
2045
2080
.
Christopher P. Landowski, Yoshiro Suzuki & Matthias A. Hediger. 2008. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney
91
146
.
Rajinder K. Bhardwaj, Dea R. Herrera-Ruiz, Yan Xu, Stephen M. Carl, Thomas J. Cook, Nicholi Vorsa & Gregory T. Knipp. 2008. Biopharmaceutics Applications in Drug Development. Biopharmaceutics Applications in Drug Development
175
261
.
Antonius E. van Herwaarden, Els Wagenaar, Cornelia M.M. van der Kruijssen, Robert A.B. van Waterschoot, Johan W. Smit, Ji-Ying Song, Martin A. van der Valk, Olaf van Tellingen, José W.A. van der Hoorn, Hilde Rosing, Jos H. Beijnen & Alfred H. Schinkel. (2007) Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. Journal of Clinical Investigation 117:11, pages 3583-3592.
Crossref
Crossref
Tomoji Maeda, Masanobu Oyabu, Takafumi Yotsumoto, Ryunosuke Higashi, Kiyoshi Nagata, Yasushi Yamazoe & Ikumi Tamai. (2007) Effect of Pregnane X Receptor Ligand on Pharmacokinetics of Substrates of Organic Cation Transporter Oct1 in Rats. Drug Metabolism and Disposition 35:9, pages 1580-1586.
Crossref
Crossref
Sébastien Bihorel, Gian Camenisch, Michel Lemaire & Jean-Michel Scherrmann. (2007)
Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec
®
) across the mouse blood-brain barrier
. Journal of Neurochemistry 102:6, pages 1749-1757.
Crossref
Crossref
Thomas J. Urban, Chen Yang, Leah L. Lagpacan, Chaline Brown, Richard A. Castro, Travis R. Taylor, Conrad C. Huang, Douglas Stryke, Susan J. Johns, Michiko Kawamoto, Elaine J. Carlson, Thomas E. Ferrin, Esteban G. Burchard & Kathleen M. Giacomini. (2007) Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). Pharmacogenetics and Genomics 17:9, pages 773-782.
Crossref
Crossref
Koen van de Wetering, Noam Zelcer, Annemieke Kuil, Wouter Feddema, Michel Hillebrand, Maria L. H. Vlaming, Alfred H. Schinkel, Jos H. Beijnen & Piet Borst. (2007) Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides. Molecular Pharmacology 72:2, pages 387-394.
Crossref
Crossref
Hermann Koepsell, Katrin Lips & Christopher Volk. (2007) Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications. Pharmaceutical Research 24:7, pages 1227-1251.
Crossref
Crossref
Johan W. Jonker, Sandra Musters, Maria L. H. Vlaming, Torsten Plösch, Karin E. R. Gooijert, Michel J. Hillebrand, Hilde Rosing, Jos H. Beijnen, Henkjan J. Verkade & Alfred H. Schinkel. (2007) Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX. American Journal of Physiology-Cell Physiology 292:6, pages C2204-C2212.
Crossref
Crossref
Yan Shu, Steven A. Sheardown, Chaline Brown, Ryan P. Owen, Shuzhong Zhang, Richard A. Castro, Alexandra G. Ianculescu, Lin Yue, Joan C. Lo, Esteban G. Burchard, Claire M. Brett & Kathleen M. Giacomini. (2007) Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. Journal of Clinical Investigation 117:5, pages 1422-1431.
Crossref
Crossref
Ho-Jin Kang, Im-Sook Song, Ho Jung Shin, Woo-Young Kim, Choong-Hee Lee, Joo-Cheol Shim, Hong-Hao Zhou, Sang Seop Lee & Jae-Gook Shin. (2007) Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population. Drug Metabolism and Disposition 35:4, pages 667-675.
Crossref
Crossref
Tomohiro Terada & Ken-ichi Inui. (2007) Gene expression and regulation of drug transporters in the intestine and kidney. Biochemical Pharmacology 73:3, pages 440-449.
Crossref
Crossref
Valentin Gorboulev & Hermann Koepsell. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference
1
4
.
Tomoko Sugiura, Yukio Kato & Akira Tsuji. (2006) Role of SLC xenobiotic transporters and their regulatory mechanisms PDZ proteins in drug delivery and disposition. Journal of Controlled Release 116:2, pages 238-246.
Crossref
Crossref
Moon Kyoung Kim & Chang-Koo Shim. (2006) The transport of organic cations in the small intestine: Current knowledge and emerging concepts. Archives of Pharmacal Research 29:7, pages 605-616.
Crossref
Crossref
Belle Lee, Laurent Decosterd, Reinhold Kerb & Amalio Telenti. 2006. Pharmacogenetics. Pharmacogenetics
155
187
.
Vera Michel, Zongfei Yuan, Shobha Ramsubir & Marica Bakovic. (2016) Choline Transport for Phospholipid Synthesis. Experimental Biology and Medicine 231:5, pages 490-504.
Crossref
Crossref
Morgan D. Fullerton, Laura Wagner, Zongfei Yuan & Marica Bakovic. (2006) Impaired trafficking of choline transporter-like protein-1 at plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages. American Journal of Physiology-Cell Physiology 290:4, pages C1230-C1238.
Crossref
Crossref
Reinhold Kerb. (2006) Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Letters 234:1, pages 4-33.
Crossref
Crossref
Richard B. Kim. (2006) Transporters and Drug Discovery: Why, When, and How. Molecular Pharmaceutics 3:1, pages 26-32.
Crossref
Crossref
Yoshimichi Sai, Yukio Kato, Keiko Nakamura, Sayaka Kato, Tomohiro Nishimura, Yoshiyuki Kubo, Ikumi Tamai, Shu Yang, Zhuhan Hu, Ichimaro Yamada & Akira Tsuji. (2006) Carrier-mediated hepatic uptake of a novel nonrenal excretion type uric acid generation inhibitor, Y-700. Journal of Pharmaceutical Sciences 95:2, pages 336-347.
Crossref
Crossref
Peter L.M. Jansen & Albert K. Groen. 2006. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
67
85
.
E. Schömig, A. Lazar & D. Gründemann. 2006. Neurotransmitter Transporters. Neurotransmitter Transporters
151
180
.
Tomohiro Terada, Yutaka Shimada, Xiaoyue Pan, Koshiro Kishimoto, Takaki Sakurai, Ryuichiro Doi, Hisashi Onodera, Toshiya Katsura, Masayuki Imamura & Ken-ichi Inui. (2005) Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tract. Biochemical Pharmacology 70:12, pages 1756-1763.
Crossref
Crossref
Harunobu Tahara, Hiroyuki Kusuhara, Hitoshi Endou, Hermann Koepsell, Tomoki Imaoka, Eiichi Fuse & Yuichi Sugiyama. (2005)
A Species Difference in the Transport Activities of H
2
Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters
. Journal of Pharmacology and Experimental Therapeutics 315:1, pages 337-345.
Crossref
Crossref
Kousei Ito, Hiroshi Suzuki, Toshiharu Horie & Yuichi Sugiyama. (2005) Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport. Pharmaceutical Research 22:10, pages 1559-1577.
Crossref
Crossref
Gracia Merino, Antonius E. van Herwaarden, Els Wagenaar, Johan W. Jonker & Alfred H. Schinkel. (2005) Sex-Dependent Expression and Activity of the ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (BCRP/ABCG2) in Liver. Molecular Pharmacology 67:5, pages 1765-1771.
Crossref
Crossref
Naoki Ishiguro, Asami Saito, Kazutoshi Yokoyama, Makoto Morikawa, Takashi Igarashi & Ikumi Tamai. (2005)
TRANSPORT OF THE DOPAMINE D
2
AGONIST PRAMIPEXOLE BY RAT ORGANIC CATION TRANSPORTERS OCT1 AND OCT2 IN KIDNEY
. Drug Metabolism and Disposition 33:4, pages 495-499.
Crossref
Crossref
Wenxian Nie, Seth Sweetser, Mary Rinella & Richard M. Green. (2005)
Transcriptional regulation of murine
Slc22a1
(Oct1) by peroxisome proliferator agonist receptor-α and -γ
. American Journal of Physiology-Gastrointestinal and Liver Physiology 288:2, pages G207-G212.
Crossref
Crossref
Giuliano Ciarimboli & Eberhard Schlatter. (2004) Regulation of organic cation transport. Pfl�gers Archiv - European Journal of Physiology 449:5, pages 423-441.
Crossref
Crossref
Hiroyuki Kusuhara & Yuichi Sugiyama. (2005) Active efflux across the blood-brain barrier: Role of the solute carrier family. NeuroRX 2:1, pages 73-85.
Crossref
Crossref
Olga L. Miakotina, Marianna Agassandian, Lei Shi, Dwight C. Look & Rama K. Mallampalli. (2005) Adenovirus stimulates choline efflux by increasing expression of organic cation transporter-2. American Journal of Physiology-Lung Cellular and Molecular Physiology 288:1, pages L93-L102.
Crossref
Crossref
Giuliano Ciarimboli, Katja Struwe, Petra Arndt, Valentin Gorboulev, Hermann Koepsell, Eberhard Schlatter & Jochen R. Hirsch. (2004) Regulation of the human organic cation transporter hOCT1. Journal of Cellular Physiology 201:3, pages 420-428.
Crossref
Crossref
Merlin C. Thomas, Christos Tikellis, Phillip Kantharidis, Wendy C. Burns, Mark E. Cooper & Josephine M. Forbes. (2004) The Role of Advanced Glycation in Reduced Organic Cation Transport Associated with Experimental Diabetes. Journal of Pharmacology and Experimental Therapeutics 311:2, pages 456-466.
Crossref
Crossref
Stephen H. Wright & William H. Dantzler. (2004) Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport. Physiological Reviews 84:3, pages 987-1049.
Crossref
Crossref
Hermann Koepsell. (2004) Polyspecific organic cation transporters: their functions and interactions with drugs. Trends in Pharmacological Sciences 25:7, pages 375-381.
Crossref
Crossref
Gerald U. Denk, Carol J. Soroka, Albert Mennone, Hermann Koepsell, Ulrich Beuers & James L. Boyer. (2004) Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis. Hepatology 39:5, pages 1382-1389.
Crossref
Crossref
Masaya Itoda, Yoshiro Saito, Keiko Maekawa, Hiroyuki Hichiya, Kazuo Komamura, Shiro Kamakura, Masafumi Kitakaze, Hitonobu Tomoike, Kazuyuki Ueno, Shogo Ozawa & Jun-ichi Sawada. (2004) Seven Novel Single Nucleotide Polymorphisms in the Human SLC22A1 Gene Encoding Organic Cation Transporter 1 (OCT1). Drug Metabolism and Pharmacokinetics 19:4, pages 308-312.
Crossref
Crossref
Toshihisa Ishikawa, Akira Tsuji, Kenichi Inui, Yoshimichi Sai, Naohiko Anzai, Morimasa Wada, Hitoshi Endou & Yasuhiro Sumino. (2004) The genetic polymorphism of drug transporters: functional analysis approaches. Pharmacogenomics 5:1, pages 67-99.
Crossref
Crossref
Johan W. Jonker & Alfred H. Schinkel. (2004) Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3). Journal of Pharmacology and Experimental Therapeutics 308:1, pages 2-9.
Crossref
Crossref
Takeshi Sakata, Naohiko Anzai, Ho Jung Shin, Rie Noshiro, Taku Hirata, Hirokazu Yokoyama, Yoshikatsu Kanai & Hitoshi Endou. (2004) Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. Biochemical and Biophysical Research Communications 313:3, pages 789-793.
Crossref
Crossref
H. Koepsell, B. M. Schmitt & V. Gorboulev. 2004. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology
36
90
.
Naomi Mizuno, Takuro Niwa, Yoshihisa Yotsumoto & Yuichi Sugiyama. (2003) Impact of Drug Transporter Studies on Drug Discovery and Development. Pharmacological Reviews 55:3, pages 425-461.
Crossref
Crossref
Yan Shu, Maya K. Leabman, Bo Feng, Lara M. Mangravite, Conrad C. Huang, Doug Stryke, Michiko Kawamoto, Susan J. Johns, Joseph DeYoung, Elaine Carlson, Thomas E. Ferrin, Ira Herskowitz & Kathleen M. Giacomini. (2003) Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proceedings of the National Academy of Sciences 100:10, pages 5902-5907.
Crossref
Crossref
De-Sheng Wang, Hiroyuki Kusuhara, Yukio Kato, Johan W. Jonker, Alfred H. Schinkel & Yuichi Sugiyama. (2003) Involvement of Organic Cation Transporter 1 in the Lactic Acidosis Caused by Metformin. Molecular Pharmacology 63:4, pages 844-848.
Crossref
Crossref
Birgitta C. Burckhardt, Stefan Brai, Sönke Wallis, Wolfgang Krick, Natascha A. Wolff & Gerhard Burckhardt. (2003) Transport of cimetidine by flounder and human renal organic anion transporter 1. American Journal of Physiology-Renal Physiology 284:3, pages F503-F509.
Crossref
Crossref
Ayako Takeuchi, Hideyuki Motohashi, Masahiro Okuda & Ken-ichi Inui. (2003) Decreased Function of Genetic Variants, Pro283Leu and Arg287Gly, in Human Organic Cation Transporter hOCT1. Drug Metabolism and Pharmacokinetics 18:6, pages 409-412.
Crossref
Crossref
Toshiya Katsura & Ken-ichi Inui. (2003) Intestinal Absorption of Drugs Mediated by Drug Transporters: Mechanisms and Regulation. Drug Metabolism and Pharmacokinetics 18:1, pages 1-15.
Crossref
Crossref
Klaas Nico Faber, Michael Müller & Peter L.M Jansen. (2003) Drug transport proteins in the liver. Advanced Drug Delivery Reviews 55:1, pages 107-124.
Crossref
Crossref
Satish A Eraly, Bruce A Hamilton & Sanjay K Nigam. (2003) Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochemical and Biophysical Research Communications 300:2, pages 333-342.
Crossref
Crossref
Kerry B. Goralski, Ganlu Lou, Matthew T. Prowse, Valentin Gorboulev, Christopher Volk, Hermann Koepsell & Daniel S. Sitar. (2002) The Cation Transporters rOCT1 and rOCT2 Interact with Bicarbonate but Play Only a Minor Role for Amantadine Uptake into Rat Renal Proximal Tubules. Journal of Pharmacology and Experimental Therapeutics 303:3, pages 959-968.
Crossref
Crossref
Johan W. JonkerMarije BuitelaarEls WagenaarMartin A. van der ValkGeorge L. SchefferRik J. ScheperTorsten PlöschFolkert KuipersRonald P. J. Oude ElferinkHilde RosingJos H. BeijnenAlfred H. Schinkel. (2002) The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proceedings of the National Academy of Sciences 99:24, pages 15649-15654.
Crossref
Crossref
Alfred H Schinkel & Johan W Jonker. (2002) Polymorphisms affecting function of the human organic cation transporter hOCT1 (SLC22A1). Pharmacogenetics 12:8, pages 589-590.
Crossref
Crossref
Dirk Gründemann, Ann-Cathrin Koschker, Christine Haag, Cornelius Honold, Tim Zimmermann & Edgar Schömig. (2002) Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells. British Journal of Pharmacology 137:6, pages 910-918.
Crossref
Crossref
Rommel G Tirona & Richard B Kim. (2002) Pharmacogenomics of organic anion-transporting polypeptides (OATP). Advanced Drug Delivery Reviews 54:10, pages 1343-1352.
Crossref
Crossref
De-Sheng Wang, Johan W. Jonker, Yukio Kato, Hiroyuki Kusuhara, Alfred H. Schinkel & Yuichi Sugiyama. (2002) Involvement of Organic Cation Transporter 1 in Hepatic and Intestinal Distribution of Metformin. Journal of Pharmacology and Experimental Therapeutics 302:2, pages 510-515.
Crossref
Crossref
Mari Kakehi, Noriko Koyabu, Takanori Nakamura, Takeshi Uchiumi, Michihiko Kuwano, Hisakazu Ohtani & Yasufumi Sawada. (2002) Functional characterization of mouse cation transporter mOCT2 compared with mOCT1. Biochemical and Biophysical Research Communications 296:3, pages 644-650.
Crossref
Crossref
Rong Chen, Johan W Jonker & J.Arly Nelson. (2002) Renal organic cation and nucleoside transport. Biochemical Pharmacology 64:2, pages 185-190.
Crossref
Crossref
Naomi Mizuno & Yuichi Sugiyama. (2002) Drug Transporters: Their Role and Importance in the Selection and Development of New Drugs. Drug Metabolism and Pharmacokinetics 17:2, pages 93-108.
Crossref
Crossref
Akira Tsuji. (2002) Transporter-mediated Drug Interactions. Drug Metabolism and Pharmacokinetics 17:4, pages 253-274.
Crossref
Crossref